A Phase I/II Pilot Study of the Safety of the Adoptive Transfer of Syngeneic Gene-Modified Cytotoxic T Lymphocytes in HIV-Infected Identical Twins. National Institutes of Health, Bethesda, Maryland
- 10 February 1996
- journal article
- clinical trial
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 7 (3) , 367-400
- https://doi.org/10.1089/hum.1996.7.3-367
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Cell-Mediated Immune Response to Human Immunodeficiency Virus (HIV) Type 1 in Seronegative Homosexual Men with Recent Sexual Exposure to HIV-1The Journal of Infectious Diseases, 1992
- Steady ProgressHuman Gene Therapy, 1991
- HIV Infection and Gene Transfer TherapyHuman Gene Therapy, 1991
- Selection of Gene-Marked Tumor Infiltrating Lymphocytes from Post-Treatment Biopsies: A Case StudyHuman Gene Therapy, 1990
- ANTI-RETROVIRAL EFFECTS OF INTERFERON-α IN AIDS-ASSOCIATED KAPOSI'S SARCOMAThe Lancet, 1988
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- CLINICAL AND IMMUNOLOGICAL RESTORATION IN PATIENTS WITH AIDS AFTER MARROW TRANSPLANTATION, USING LYMPHOCYTE TRANSFUSIONS FROM THE MARROW DONORTransplantation, 1987
- Partial Immune Reconstitution in a Patient with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1984
- Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.Journal of Clinical Investigation, 1983
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983